Aurora Cannabis Inc. (ACB)

7.46
0.05 0.67
NYSE : Health Technology
Prev Close 7.51
Open 7.52
Day Low/High 7.42 / 7.66
52 Wk Low/High 4.05 / 12.53
Volume 8.05M
Avg Volume 16.27M
Exchange NYSE
Shares Outstanding 1.01B
Market Cap 7.64B
EPS 0.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

This Is Canopy Growth's Must-Hold Support Level

This Is Canopy Growth's Must-Hold Support Level

Canopy Growth stock is taking a beating on Friday after the company disappointed investors with its quarterly results. Here's the must-hold support level for the stock now.

Reducing a Winner

We’ll trim our position in Aurora Cannabis in order to protect some gains.

Canopy Growth Slips as Production, Margins Disappoint

Canopy Growth Slips as Production, Margins Disappoint

While the cannabis company's stock is sliding on its year-end report, at least one analyst sees a long-term buying opportunity.

Stocks Under $10 Weekly Summary

With the market rising last week, we saw favorable action in several of our holdings and booked some hefty gains in one name.

Young Folks Are High on a Current Name, and We Plug Another Into the Bullpen

An investing app indicates Aurora Cannabis is popular with young investors, while we also intend to monitor alternative energy firm Plug Power.

Stocks Under $10 Weekly Summary

With the market rebounding, the majority of our positions rose week over week.

Tilray Is Tough to Trade as It Breaks Out of a Nasty Downtrend

Tilray Is Tough to Trade as It Breaks Out of a Nasty Downtrend

Tilray is erupting higher and breaking over downtrend resistance. It's been a long time coming for this troubled cannabis stock.

Cannabis Virtual Investor Conference Presentations Now Available For On-Demand Viewing

Cannabis Virtual Investor Conference Presentations Now Available For On-Demand Viewing

Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view the presentations

Cronos Jumps on Double Upgrade, Tilray Initiated With Perform Rating

Cronos Jumps on Double Upgrade, Tilray Initiated With Perform Rating

Bank of America lifts its price target on Cronos to $20 from $13.

Stocks Under $10 Weekly Summary

During the week, we exited our position in KushCo Holdings and initiated Antares Pharma.

Cannabis Stocks Lower as FDA Hearing on CBD-Infused Foods Gets Underway

Cannabis Stocks Lower as FDA Hearing on CBD-Infused Foods Gets Underway

The FDA will discuss the safety and product quality of CBD-derived compounds in a public hearing Friday.

Live Investor Conference & Webinar: Cannabis Industry Companies Present June 4th

Live Investor Conference & Webinar: Cannabis Industry Companies Present June 4th

Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com

Ben & Jerry's Wants to Get in on CBD Craze

Ben & Jerry's Wants to Get in on CBD Craze

The company's announcement comes ahead of an FDA's public hearing on the legalization of CBD-infused foods and beverages on Friday.

Stocks Under $10 Weekly Summary

Several positive moves along with our cash position helped insulate the overall portfolio’s performance from last week's market decline.

A Holding With a Fighting Chance to Score a Knockout

Aurora Cannabis has reached an agreement with the UFC to study the effect of CBD-infused products on athlete recovery and wellness; we also glance at J.C. Penney post-earnings.

Aurora Cannabis Enters Partnership With UFC to Advance Marijuana Research

Aurora Cannabis Enters Partnership With UFC to Advance Marijuana Research

The partnership is a multi-year, multi-million dollar global research partnership that looks to establish a link between CBD products and athlete wellness and recovery.

Aurora Cannabis And UFC® Join Forces To Advance CBD Research, Education, And Product Development

Aurora Cannabis And UFC® Join Forces To Advance CBD Research, Education, And Product Development

Multi-Year Global Partnership will Advance Science on Athlete Health and Wellness NYSE: ACB   TSX:ACB            EDMONTON, May 21, 2019 /PRNewswire/ - Aurora Cannabis Inc.

Stocks Under $10 Weekly Summary

Amid renewed trade and geopolitical tensions, we trimmed our position in Energy Recovery and added a short-term trade in J.C. Penney.

Aurora Cannabis Up 2.4%; Tera Tech Off 5.6%: Cannabis Stocks Mixed

Aurora Cannabis Up 2.4%; Tera Tech Off 5.6%: Cannabis Stocks Mixed

Gainers trail losers in Cannabis sector action Thursday.

Aurora Cannabis Up 3.6%, General Cannabis Off 2.9%; cbdMD Due to Report

Aurora Cannabis Up 3.6%, General Cannabis Off 2.9%; cbdMD Due to Report

Gainers lead losers a day after financial results from Aurora and Tilray.

Stocks Finish Higher For Second Day on Possible Delay of Auto Tariffs

Stocks Finish Higher For Second Day on Possible Delay of Auto Tariffs

Stocks end higher following a report that the Trump administration plans to delay auto tariffs for six months.

Trimming a Position and What to Make of an Earnings Report

Energy Recovery has stabilized above our target, warranting some action. Plus, Aurora Cannabis reports earnings.

Can Aurora Cannabis Go Higher Despite Earnings Miss?

Can Aurora Cannabis Go Higher Despite Earnings Miss?

Aurora Cannabis is well off the lows, but not posting a very big move on earnings. Here are the must-know breakout and breakdown levels to watch.

One Thing Investors Need to Know Before Investing in Cannabis

One Thing Investors Need to Know Before Investing in Cannabis

Action Alerts Plus senior analyst Jeff Marks has some advice for investors looking to invest in cannabis and what they should be watching.

Three Things to Watch in the Cannabis Sector After Tilray and Aurora's Earnings

Three Things to Watch in the Cannabis Sector After Tilray and Aurora's Earnings

Curious about the cannabis sector? Here's what Tilray and Aurora's earnings mean for the sector.

What You Need to Know About the Markets, Macy's, Tilray, and Aurora Earnings

What You Need to Know About the Markets, Macy's, Tilray, and Aurora Earnings

Is the market oversold? What should investors need to know about Tilray, Aurora and Macy's earnings? Here's what investors need to know according to Action Alerts Plus senior analyst Jeff Marks and Real Money reporter Kevin Curran.

What Investors Need to Know About the Trade War, What It Means for Retail - LIVE

What Investors Need to Know About the Trade War, What It Means for Retail - LIVE

It's time to tackle the markets, and earnings from Macy's, Tilray and Aurora. Join Katherine Ross, Jeff Marks and Kevin Curran as they discuss the biggest market headlines.

Tilray Shares Jump After Q1 Revenue Beat; Aurora Slides as Sales Miss Forecasts

Tilray Shares Jump After Q1 Revenue Beat; Aurora Slides as Sales Miss Forecasts

Tilray shares traded higher Wednesday after the Canadian cannabis group posted stronger-than-expected first quarter sales, while its domestic rival Aurora Cannabis slumped after its revenues missed analysts' forecast amid caps on retail store growth in the Canadian market.

TheStreet Quant Rating: C- (Hold)